Dopamine and Dobutamine Use in Preterm or Low Birth Weight Neonates in the Premier 2008 Database

Clinical Therapeutics

Volumn 33, Issue 12, 2011, Pages 2082-2088

  Lasky, Tamar ^a   Greenspan, Jay ^b   Ernst, Frank R ^c   Gonzalez, Liliana ^d  

^a MIE Resources   (United States)

^b NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^c Premier Research   (United States)

^d University of Rhode Island   (United States)

Author keywords

Database; Dobutamine; Dopamine; Hospitalization; Neonates; Pharmacoepidemiology

Indexed keywords

DOBUTAMINE; DOPAMINE;

ARTICLE; DISEASE SEVERITY; DRUG UTILIZATION; FEMALE; HUMAN; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; NEWBORN; NEWBORN MORTALITY; OUTCOME ASSESSMENT; PREMATURITY; PREVALENCE; SURVIVAL RATE;

CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; DATABASES AS TOPIC; DOBUTAMINE; DOPAMINE; DRUG UTILIZATION; FEMALE; HUMANS; INFANT MORTALITY; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; MALE; PHYSICIAN'S PRACTICE PATTERNS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 83455201530     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2011.11.001     Document Type: Article

References (25)

1. Ward R.M., Benitz W.E., Benjamin D.K., et al. Criteria supporting the study of drugs in the newborn. Clin Ther 2006, 28:1385-1398.
2. Best Pharmaceuticals for Children Act. Literature reviews and literature assessments National Institute of Child Health and Human Development, Accessed November 15, 2011. http://bpca.nichd.nih.gov/resources/reviews/index.cfm.
3. List of Drugs for Which Pediatric Studies Are Needed. Fed Regist 2003, 68:2789-2790. Department of Health and Human Services.
4. Dempsey E.M., Barrington K.J. Treating hypotension in the preterm infant: when and with what: a critical and systematic review. J Perinatol 2007, 27:469-478.
5. Osborn D.A., Evans N., Kluckow M. Left ventricular contractility in extremely premature infants in the first day and response to inotropes. Pediatr Res 2007, 61:335-340.
6. Raab E., Seri I. Diagnosis and treatment of the hypotensive very low birth weight infant during postnatal transition. J Perinatol 2006, 26:657-659.
7. Batton B., Batton D., Riggs T. Blood pressure during the first 7 days in premature infants born at postmenstrual age 23 to 25 weeks. Am J Perinatol 2007, 24:107-116.
8. Evans J.R., Lou Short B., Van Meurs K., Cheryl Sachs H. Cardiovascular support in preterm infants. Clin Ther 2006, 28:1366-1384.
9. Hunt R., Osborn D. Dopamine for prevention of morbidity and mortality in term newborn infants with suspected perinatal asphyxia. Cochrane Database Syst Rev 2002, 3. CD003484.
10. Giacoia G.P., Birenbaum D.L., Sachs H.C., Mattison D.R. The newborn drug development initiative. Pediatrics 2006, 117:S1-S8.
11. Greenough A., Emery E.F. Randomized trial comparing dopamine and dobutamine in preterm infants. Eur J Pediatr 1993, 152:925-927.
12. Hentschel R., Hensel D., Brune T., et al. Impact on blood pressure and intestinal perfusion of dobutamine or dopamine in hypotensive preterm infants. Biol Neonate 1995, 68:318-324.
13. Klarr J.M., Faix R.G., Pryce C.J., Bhatt-Mehta V. Randomized, blind trial of dopamine versus dobutamine for treatment of hypotension in preterm infants with respiratory distress syndrome. J Pediatr 1994, 125:117-122.
14. Osborn D., Evans N., Kluckow M. Randomized trial of dobutamine versus dopamine in preterm infants with low systemic blood flow. J Pediatr 2002, 140:183-191.
15. Roze J.C., Tohier C., Maingueneau C., et al. Response to dobutamine and dopamine in the hypotensive very preterm infant. Arch Dis Child 1993, 69:59-63.
16. Subhedar N.V., Shaw N.J. Dopamine versus dobutamine for hypotensive preterm infants. Cochrane Database Syst Rev 2003, 3. CD001242.
17. Premier Perspective Database 2008, Premier Research Services, Premier, Inc, Charlotte, NC, Accessed November 16, 2011. http://www.premierinc.com/quality-safety/tools-services/prs/data/perspective.jsp.
18. Hughes J. Development of the 3M All Patient Refined Diagnosis Related Groups (APR DRGs). Mortality Measurement Meeting; November 3, 2008 2008, Department of Health and Human Services, Cambridge, Mass.
19. Remington R.D., Schork M.A. Statistics with Applications to the Biological and Health Sciences 1970, Prentice-Hall, Inc, Englewood Cliffs.
20. Al-Aweel I., Pursley D.M., Rubin L.P., et al. Variations in prevalence of hypotension, hypertension, and vasopressor use in NICUs. J Perinatol 2001, 21:272-278.
21. Laughon M., Bose C., Allred E., et al. Factors associated with treatment for hypotension in extremely low gestational age newborns during the first postnatal week. Pediatrics 2007, 119:273-280.
22. Giacoia G.P., Mattison D.R. Newborns and drug studies: the NICHD/FDA newborn drug development initiative. Clin Ther 2005, 27:796-813.
23. Short B.L., Van Meurs K., Evans J.R. Summary proceedings from the cardiology group on cardiovascular instability in preterm infants. Pediatrics 2006, 117. S34-S9.
24. Baer G.R., Nelson R.M. Ethical challenges in neonatal research: summary report of the ethics group of the newborn drug development initiative. Clin Ther 2006, 28:1399-1407.
25. Early blood pressure management in extremely premature infants (ELGAN BP) U.S. National Institutes of Health, Accessed November 15, 2011. http://clinicaltrials.gov/ct2/show/NCT00874393?term=early+blood+pressure&rank=1.